Donor Mesenchymal Stromal Cells (MSCs) Undergo Variable Cardiac Reprogramming in Vivo and Predominantly Co-Express Cardiac and Stromal Determinants after Experimental Acute Myocardial Infarction

2013 ◽  
Vol 10 (2) ◽  
pp. 304-315 ◽  
Author(s):  
Gustavo Yannarelli ◽  
James N. Tsoporis ◽  
Jean-Francois Desjardins ◽  
Xing Hua Wang ◽  
Ali Pourdjabbar ◽  
...  
2011 ◽  
Vol 106 (6) ◽  
pp. 1299-1310 ◽  
Author(s):  
Victor Dayan ◽  
Gustavo Yannarelli ◽  
Filio Billia ◽  
Paola Filomeno ◽  
Xing-Hua Wang ◽  
...  

2009 ◽  
Vol 2009 ◽  
pp. 1-8 ◽  
Author(s):  
Katarina Kollar ◽  
Matthew M. Cook ◽  
Kerry Atkinson ◽  
Gary Brooke

Mesenchymal stem cells or multipotent mesenchymal stromal cells (both referred to as MSC) have been shown in some studies to have a beneficial effect on myocardial recovery after infarct. Current strategies for MSC delivery to heart involve intravenous, intraarterial, and intramuscular delivery. Different routes of MSC delivery and a lack of knowledge of the mechanisms that MSC utilise to migrate in vivo has most likely led to the marked variations in results that have been found. This review aims to summarise the current knowledge of MSC migratory mechanisms and looks to future methods of MSC manipulation prior to delivery in order to enhance MSC migration and engraftment.


Cytotherapy ◽  
2015 ◽  
Vol 17 (3) ◽  
pp. 250-261 ◽  
Author(s):  
Anoop Chullikana ◽  
Anish Sen Majumdar ◽  
Sanjay Gottipamula ◽  
Sagar Krishnamurthy ◽  
A. Sreenivas Kumar ◽  
...  

Cytotherapy ◽  
2015 ◽  
Vol 17 (10) ◽  
pp. 1365-1373 ◽  
Author(s):  
Jian Cao ◽  
Xiao Li ◽  
Ning Chang ◽  
Yining Wang ◽  
Jing Lei ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document